6.71
Kamada Ltd stock is traded at $6.71, with a volume of 47,990.
It is up +0.15% in the last 24 hours and down -2.61% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$6.70
Open:
$6.63
24h Volume:
47,990
Relative Volume:
0.23
Market Cap:
$385.28M
Revenue:
$154.57M
Net Income/Loss:
$15.07M
P/E Ratio:
24.85
EPS:
0.27
Net Cash Flow:
$10.92M
1W Performance:
-2.75%
1M Performance:
-2.61%
6M Performance:
+28.30%
1Y Performance:
+20.68%
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
KMDA
Kamada Ltd
|
6.71 | 385.28M | 154.57M | 15.07M | 10.92M | 0.27 |
![]()
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-21-25 | Initiated | The Benchmark Company | Buy |
Jul-03-24 | Initiated | Stifel | Buy |
Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Kamada (NASDAQ:KMDA) Downgraded by StockNews.com to “Buy” - Defense World
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders - GlobeNewswire
Kamada Ltd. announces dividend tax details By Investing.com - Investing.com Australia
Kamada Ltd. announces dividend tax details - Investing.com
Kamada Announces Tax Ruling on Special Cash Dividend - TipRanks
Kamada Shareholders Alert: How to Save on Dividend TaxKey Deadlines Revealed - Stock Titan
Kamada (NASDAQ:KMDA) Earns Buy Rating from Analysts at Benchmark - The AM Reporter
Kamada (NASDAQ:KMDA) Coverage Initiated at Benchmark - Defense World
Kamada Ltd’s Growth at Risk: Manufacturing Capacity and Expansion Challenges Loom Large - MSN
Benchmark Initiates Coverage of Kamada (KMDA) with Buy Recommendation - Nasdaq
Benchmark raises Kamada stock target to $15, initiates with Buy By Investing.com - Investing.com Canada
Benchmark raises Kamada stock target to $15, initiates with Buy - Investing.com
Kamada Ltd. expands plasma collection with new Texas site By Investing.com - Investing.com South Africa
Kamada at Sidoti Small-Cap Conference: Strategic Growth and Future Plans - Investing.com Australia
Kamada Expands Plasma Collection With New Texas Facility -March 19, 2025 at 09:37 am EDT - Marketscreener.com
Kamada opens plasma center with 50,000-liter capacity - Investing.com
Kamada Ltd. expands plasma collection with new Texas site - Investing.com
Kamada Expands Plasma Collection Operations with New San Antonio Center - TipRanks
Kamada opens third plasma collection center in San Antonio, Texas - TipRanks
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas - GlobeNewswire
Kamada's New Texas Plasma Center to Generate $10M Annual Revenue - StockTitan
StockNews.com Upgrades Kamada (NASDAQ:KMDA) to Strong-Buy - Defense World
Kamada Delivers Record Financial Performance, Projects Continued Growth in 2025 - citybuzz -
Kamada Announces Dividend After Record-Breaking Year, Anticipates Further Double-Digit Growth - Financial Content
Kamada Ltd. Reports Record 2024 Financial Results - TipRanks
HC Wainwright Has Pessimistic View of Kamada FY2025 Earnings - Defense World
HC Wainwright Reaffirms “Buy” Rating for Kamada (NASDAQ:KMDA) - Defense World
Research Analysts Set Expectations for Kamada Q1 Earnings - Defense World
H.C. Wainwright maintains $11 target on Kamada stock By Investing.com - Investing.com South Africa
Kamada Ltd. (NASDAQ:KMDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Kamada: Q4 Earnings Snapshot - Barchart
Kamada Ltd (KMDA) Q4 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Kamada Ltd (KMDA) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - Yahoo Finance
Kamada Ltd Reports Record 2024 Earnings and Positive 2025 Outlook - TipRanks
Kamada Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Kamada Ltd. announces special dividend, robust 2024 results By Investing.com - Investing.com South Africa
Earnings call transcript: Kamada Q4 2024 beats EPS forecast, stock rises By Investing.com - Investing.com South Africa
Kamada Ltd. announces special dividend, robust 2024 results - Investing.com India
Earnings call transcript: Kamada Q4 2024 beats EPS forecast, stock rises - Investing.com UK
Kamada Declares Special Cash Dividend of $0.20 per Share; Payable April 7 to Shareholders of Record as of March 17 - MarketScreener
Kamada shares rise as 2% as Q4 earnings top estimates By Investing.com - Investing.com Australia
Kamada Announces Special Dividend Following Record 2024 Financial Results - TipRanks
Kamada Declares Special Cash Dividend of $0.20 Per Share - GlobeNewswire
Kamada Reports Record Top and Bottom Line 2024 Financial - GlobeNewswire
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):